Specialty code 183500000X · Glendale, AZ
NPI
1760868996
Since 2015
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
19389 N 59th Ave
Glendale, AZ, 85308
Phone (623) 537-6000
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.5M
545 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Mardoqueo J Martinez III prescribed most often to Medicare patients was Furosemide, with 49 prescriptions and refills. In total Mardoqueo J Martinez III wrote 545 Medicare prescriptions that cost $1.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Furosemide Generic | 49 | 86 | 15 | $370 |
| Spironolactone Generic | 41 | 73 | 14 | $691 |
| Xifaxan Rifaximin | 38 | 38 | Under 11 | $117K |
| Mavyret Glecaprevir/Pibrentasvir | 35 | 35 | 17 | $468K |
| Carvedilol Generic | 30 | 72 | 11 | $432 |
| Propranolol Hcl Generic | 18 | 28 | Under 11 | $283 |
| Midodrine Hcl Generic | 17 | 17 | Under 11 | $367 |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 15 | 15 | Under 11 | $84K |
| Acamprosate Calcium Generic | 14 | 14 | Under 11 | $1,492 |
| Entecavir Generic | 14 | 16 | Under 11 | $5,570 |
| Naltrexone Hcl Generic | 14 | 20 | Under 11 | $949 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 13 | 13 | Under 11 | $145 |
| Lactulose Generic | 13 | 19 | Under 11 | $979 |
| Ozempic Semaglutide | 12 | 15 | Under 11 | $11K |
| Skyrizi On-Body Risankizumab-Rzaa | 12 | 22 | Under 11 | $238K |
Brand drugs: 205 claims; generic drugs: 340 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Mardoqueo J Martinez III were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.